Recent Investments By Top Activist Investors Include Bausch + Lomb, Twitter, BBBY & GameStop

| Getty Images Key Takeaways Activist investors attempt to purchase enough shares in a company so that they can pressure management into changes they believe will improve shareholder value. As seen wi...

Bausch Health Stock Halted After Patent Ruling. What Happens Next.

Text size Bausch Health stock was on pace for its lowest close since November 1995. Timothy Fadek/Bloomberg A federal court ruling has dealt a blow to Bausch Health by appearing to clear the way for g...

Bausch Health stock plummets toward 27-year low after Bloomberg report of unfavorable court ruling

Shares of Bausch Health Companies Inc. BHC, -41.24% suffered a near-record plunge of 50.3% in volatile afternoon trading Thursday before a trading halt, after Bloomberg reported that some of the drug ...

Bausch Health, Meta, Comcast, Qualcomm and more

In this photo illustration, a silhouetted woman holds a smartphone with the Meta Platforms, Inc. logo displayed on the screen. Rafael Henrique | Lightrocket | Getty Images Check out the companies maki...

BHC Stock Plummets On Unexpected Loss As Bausch & Lomb IPO Launches

Bausch Health Companies (BHC) reported an unexpected first-quarter loss on Tuesday and BHC stock crashed. X During the March quarter, the pharma company lost 43 cents per share on $1.92 billion in sal...

What To Expect When Bausch Health Companies Reports Q1 Tomorrow

Morningstar Research Analyst Report: Bausch Health Companies Inc. Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device com...

Bausch + Lomb: eyecare IPO does not signal thaw in new listing market

In a poor year for new US listings, Bausch + Lomb should have offered a bit of cheer. The Canadian eyecare products maker successfully raised $630mn this week. That made it the second biggest initial ...

Bausch + Lomb, Year’s Second-Biggest IPO, Pops in Public Debut

Text size Bausch + Lomb’s IPO is the second-biggest so far this year. Scott Olson/Getty Images Eye-care company Bausch + Lomb and biotech PepGen kicked off their lives as public companies Friday...

Marvell Technology and Bausch Health are buys

Bausch Health: “We wanted to buy more today, but we ran out of time. This thing is being put on sale. There are shorts taking it all the way down. It is quite ridiculous. I wanted to be able to ...

I’m sticking with Bausch Health

Tredegar Corp: “I remember when they became public. I was involved in the deal. I thought it was terrific then, I think it’s terrific now.” Bausch Health Companies Inc: “Joe Pa...

Bausch Health is a buy

SoFi Technologies Inc: “[CEO] Anthony Noto is not a loser, he is a winner and he will get this thing going. It is very low at $8 and yet I like it.” Zim Integrated Shipping: “It̵...